EP300 and prostate cancer: RNA sequencing data from primary and metastatic castration-resistant prostate cancer tissues show that CBP and p300 mRNAs are over-expressed in tumor than normal tissues, and that CBP and p300 expression positively correlates with androgen receptor expression, androgen receptor signature, and androgen deprivation therapy resistance 67.